ReviewOne health outlook2025
Ecological determinants driving orthohantavirus prevalence in small mammals of Europe: a systematic review.
Review in One health outlook, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Small rodents, huge impact: A scoping review of EuropeanOne health (Amsterdam, Netherlands) · 2026Review
- The Changing Landscape of Hantavirus Infections: A Narrative Review of Epidemiology, Pathogenesis, and Countermeasures.Reviews in medical virology · 2026Review
- Human Orthohantavirus Infections: A Narrative Review.Pathogens (Basel, Switzerland) · 2026Review
- Orthohantavirus Infection Mimicking Acute Viral Hepatitis: An Underrecognized Clinical Presentation.Pathogens (Basel, Switzerland) · 2026Review
- Integrated Downstream Analysis and Epidemiological Modelling of Hantavirus Infection: From Host Transcriptomics to Transmission Dynamics.Pathogens (Basel, Switzerland) · 2026Article
- Increasing spatial scale of analysis weakens and can mask the dilution effect for hantaviruses.PLOS global public health · 2026Article
- Climate change, rodent ecology, and the rising risk of hantavirus outbreaks: an alarming public health concern.Frontiers in microbiology · 2026Article
- Hantavirus as a persistent zoonotic risk: epidemiology and current pharmacological management.Frontiers in pharmacology · 2026Review
- Amplification-free detection of zoonotic viruses using Cas13 and multiple CRISPR RNAs.The Journal of general virology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Orthohantaviruses are emerging zoonotic pathogens that cause severe human disease and are considered an emerging public health threat globally. Mammalian orthohantaviruses are naturally maintained in rodent species and occasionally in other mammals. The abundance and density of natural orthohantavirus reservoir species are affected by multi annual and seasonal population cycles, community composition, ecosystem variables and climate. Horizontal transmission between host species is mostly density-driven and occurs via contact with infected host excreta, thus, fluctuations in populations and environmental variables often determine the prevalence of hantavirus in natural hosts. Given the zoonotic potential of hantaviruses, ecological factors influencing their spread and persistence in their natural reservoir and population dynamics influencing horizontal transmission require critical evaluation for human infection risk assessment. The present review paper discusses the impacts of natural host population cycles and ecosystem diversity, environmental conditions, and abiotic factors on the epidemiology of rodent-borne hantavirus infections in Europe. While significant efforts have been made to understand the drivers of hantavirus prevalence in natural hosts, we highlight key challenges in evaluating viral prevalence and assessing the role of environmental and population variables in determining hantavirus prevalence in host species.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.